RecruitingNCT06554145
Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens
Sponsor
GramEye
Enrollment
15,000 participants
Start Date
Sep 25, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this research is to develop an AI that estimates bacterial species from Gram staining images of urine specimens, and to evaluate the accuracy and labor reduction effect of Gram staining Automation system equipped with this AI.
Eligibility
Plain Language Summary
Simplified for easier understanding
This study is developing and evaluating an artificial intelligence (AI) program that analyzes urine Gram stain images — a standard microscopy test done in hospital labs — to predict what type of bacteria is causing a urinary tract infection (UTI). The goal is to help doctors identify the infection faster, before full culture results are available.
**You may be eligible if...**
- Your urine sample has been sent for both a urine culture and a Gram stain test as part of your routine clinical care
**You may NOT be eligible if...**
- A request has been made to withdraw your sample from the study
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06554145
Related Trials
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
NCT0564510762 locations
Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.
NCT067040481 location
A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
NCT070177773 locations
[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects
NCT042637921 location
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
NCT065925866 locations